These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9055038)

  • 1. Stability of stereoregular oligo(nucleoside phosphorothioate)s in human plasma: diastereoselectivity of plasma 3'-exonuclease.
    Koziołkiewicz M; Wójcik M; Kobylańska A; Karwowski B; Rebowska B; Guga P; Stec WJ
    Antisense Nucleic Acid Drug Dev; 1997 Feb; 7(1):43-8. PubMed ID: 9055038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereo-enriched phosphorothioate oligodeoxynucleotides: synthesis, biophysical and biological properties.
    Yu D; Kandimalla ER; Roskey A; Zhao Q; Chen L; Chen J; Agrawal S
    Bioorg Med Chem; 2000 Jan; 8(1):275-84. PubMed ID: 10968287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P-chirality-dependent immune activation by phosphorothioate CpG oligodeoxynucleotides.
    Krieg AM; Guga P; Stec W
    Oligonucleotides; 2003; 13(6):491-9. PubMed ID: 15025915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereodifferentiation--the effect of P chirality of oligo(nucleoside phosphorothioates) on the activity of bacterial RNase H.
    Koziolkiewicz M; Krakowiak A; Kwinkowski M; Boczkowska M; Stec WJ
    Nucleic Acids Res; 1995 Dec; 23(24):5000-5. PubMed ID: 8559657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzymatic assignment of diastereomeric purity of stereodefined phosphorothioate oligonucleotides.
    Koziołkiewicz M; Owczarek A; Gendaszewska E
    Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):171-81. PubMed ID: 10355823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereocontrolled synthesis of oligonucleoside phosphorothioates and PO/PS-chimeric oligonucleotides by using oxazaphospholidine derivatives.
    Oka N; Yamamoto M; Sato T; Wada T
    Nucleic Acids Symp Ser (Oxf); 2008; (52):335-6. PubMed ID: 18776390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of divalent cations on the catalytic activity of the human plasma 3'-exonuclease.
    Wojcik M; Stec WJ
    Biometals; 2010 Dec; 23(6):1113-21. PubMed ID: 20589414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human immunodeficiency virus type 1 replication by P-stereodefined oligo(nucleoside phosphorothioate)s in a long-term infection model.
    Inagawa T; Nakashima H; Karwowski B; Guga P; Stec WJ; Takeuchi H; Takaku H
    FEBS Lett; 2002 Sep; 528(1-3):48-52. PubMed ID: 12297278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoside alpha-thiotriphosphates, polymerases and the exonuclease III analysis of oligonucleotides containing phosphorothioate linkages.
    Yang Z; Sismour AM; Benner SA
    Nucleic Acids Res; 2007; 35(9):3118-27. PubMed ID: 17452363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of 3'-exonuclease stereoselectivity on the kinetics of phosphorothioate oligonucleotide metabolism.
    Gilar M; Belenky A; Budman Y; Smisek DL; Cohen AS
    Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):35-42. PubMed ID: 9512094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phosphorothioate chirality on i-motif structure and stability.
    Kanaori K; Sakamoto S; Yoshida H; Guga P; Stec W; Tajima K; Makino K
    Biochemistry; 2004 May; 43(19):5672-9. PubMed ID: 15134441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereodefined phosphorothioate analogues of DNA: relative thermodynamic stability of the model PS-DNA/DNA and PS-DNA/RNA complexes.
    Boczkowska M; Guga P; Stec WJ
    Biochemistry; 2002 Oct; 41(41):12483-7. PubMed ID: 12369839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of P-chirality of oligo(deoxyribonucleoside phosphorothioate)s on the activity of terminal deoxyribonucleotidyl transferase.
    Koziołkiewicz M; Maciaszek A; Stec WJ; Semizarov D; Victorova L; Krayevsky A
    FEBS Lett; 1998 Aug; 434(1-2):77-82. PubMed ID: 9738455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of phosphorothioate oligonucleotides with stereodefined phosphorothioate linkages.
    Guga P; Stec WJ
    Curr Protoc Nucleic Acid Chem; 2003 Oct; Chapter 4():Unit 4.17. PubMed ID: 18428907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereocontrolled solid-phase synthesis of phosphorothioate oligoribonucleotides using 2'-O-(2-cyanoethoxymethyl)-nucleoside 3'-O-oxazaphospholidine monomers.
    Nukaga Y; Yamada K; Ogata T; Oka N; Wada T
    J Org Chem; 2012 Sep; 77(18):7913-22. PubMed ID: 22931131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid support synthesis of all-Rp-oligo(ribonucleoside phosphorothioate)s.
    Almer H; Stawinski J; Strömberg R
    Nucleic Acids Res; 1996 Oct; 24(19):3811-20. PubMed ID: 8871563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology.
    Gao WY; Han FS; Storm C; Egan W; Cheng YC
    Mol Pharmacol; 1992 Feb; 41(2):223-9. PubMed ID: 1371582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of potent phosphorothioate antisense oligonucleotides directed to human interleukin 10 gene product and their evaluation of antisense activity in U937 cells.
    Arima H; Takahashi M; Aramaki Y; Sakamoto T; Yuda K; Akiyama K; Goto T; Tsuchiya S
    Pharm Res; 1999 Aug; 16(8):1163-71. PubMed ID: 10468015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorothioate oligonucleotide-directed triple helix formation.
    Hacia JG; Wold BJ; Dervan PB
    Biochemistry; 1994 May; 33(18):5367-9. PubMed ID: 8180158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing sulfur-binding domains to separate Sp and Rp isomers of phosphorothioate oligonucleotides.
    Ge F; Wang Y; Liu J; Yu H; Liu G; Deng Z; He X
    Appl Microbiol Biotechnol; 2024 Aug; 108(1):448. PubMed ID: 39190037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.